Barbara K. Finck's most recent trade in Forte Biosciences Inc was a trade of 31,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Forte Biosciences Inc | Barbara K. Finck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2025 | 31,000 | 31,000 | - | - | Stock Option (right to buy) | |
| Forte Biosciences Inc | Barbara K. Finck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Forte Biosciences Inc | Barbara K. Finck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | |
| Comera Life Sciences Holdings | Barbara K. Finck | Director | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 04 Jan 2023 | 6,756 | 23,033 | - | 1.2 | 8,310 | Common Stock |
| Comera Life Sciences Holdings | Barbara K. Finck | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Jan 2023 | 6,756 | 6,756 | - | - | Warrant (Right to Buy) | |
| Comera Life Sciences Holdings | Barbara K. Finck | Director | 31 Dec 2022 | 37,111 | 37,111 | - | - | Stock Option (Right to Buy) | ||
| Forte Biosciences Inc | Barbara K. Finck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Forte Biosciences Inc | Barbara K. Finck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 4,166 | 4,166 | - | - | Stock Option (right to buy) |